ALB and sarcoma: Alternatively, this situation might reflect technical limitations of exome sequencing approach, which does not readily detect structural variants (gene fusions, deletions, gene amplification) that are commonly found in other sarcomas, but which are not suspected to play a large role in HSA [9].